Medtech Fundraising Realities: What Founders Need to Know


At an LSI Europe emerging medtech summit, a panel of seasoned investors and medtech innovators convened to deliver a message medtech founders needed to hear: yes, it’s hard to raise capital right now — but there’s light at the end of the tunnel. The session, titled Light at the End of the Tunnel in Medtech Financing, provided a frank and tactical look at how to navigate today’s fundraising climate.

Visit here: https://shorturl.at/8vPLA

The Middle Path to Innovation | LSI Europe '24

Duke’s Keynote is based on his recently published thesis, "The Middle Path to Innovation," published in the Harvard Business Review. He discusses strategies for developing high-growth products in slow-growth companies and present the growth driver model.

The Global Stage for Live-Saving Innovation


We’re continuing to push the bar by bringing bold ideas and new capital into medtech. This year, we are thrilled to have Harry Stebbings, Founder of 20VC, join us to discuss lessons from the best founders, the AI landscape, and its impact on healthcare.

Amber Therapeutics’ Series A: Behind the $100M Raise

During a panel at LSI Europe ’24, Amber’s CEO and Co-Founder Aidan Crawley joined a panel of investors to unpack how the round came together, what made Amber a standout, and why the hard work has only just begun.

www.flipgorilla.com

Amber Therapeutics’ Series A: Behind the $100M Raise - flipgorilla

During a panel at LSI Europe ’24, Amber’s CEO and Co-Founder Aidan Crawley joined a panel of investors to unpack how the round came together, what made Amber a standout, and why the hard work has only just begun.

Marcin Golebicki, EP Solutions SA - Improve Cardiac Resynchronisation Therapy | LSI Europe '24

EP Solutions develops technology that will help physicians achieve better outcomes for heart failure patients indicated for Cardiac Resynchronisation Therapy.

Visit here for more details: https://www.lsieuropesummit.com/